Wealth Growth Daily

Top News

Nasdaq Surges Over 1% Fifth Third Bancorp Earnings Top Views

BY Avi Kapoor  • October 19, 2026October 19, 2026
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 1% on Monday. Following the market opening Monday, the Dow traded down 0.12% to 51,940.39 while the NASDAQ jumped 1.0[...]
Read more
Top News

We Asked ChatGPT, Grok and Claude for 1 Stock to Buy This Week. No One Picked Tesla.

BY Erica Kollmann  • October 19, 2026October 19, 2026
Three AI chatbots were asked for one stock to buy this week, and each came back with a different company from a different corner of the market. ChatGPT chose GE Aerospace (NYSE:GE), Grok chose Netflix[...]
Read more
Top News

Bitcoin, Ethereum or Solana? Raoul Pal Calls One ‘Wildly Undervalued’

BY Parshwa Turakhiya  • October 16, 2026October 16, 2026
Ethereum (CRYPTO: ETH) is “wildly undervalued,” according to Real Vision CEO Raoul Pal, even as he admits to also holding Bitcoin (CRYPTO: BTC), Solana (CRYPTO: SOL) and Sui (CRYPTO: SUI). Why Pal Cal[...]
Read more
Top News

ASML Could Swing $34.8 Billion After Earnings

BY Kaustubh Bagalkote  • October 13, 2026October 14, 2026
Earnings are set to hit the tape on Wednesday, before the opening bell, and options traders aren’t waiting around for the headlines — they’re already putting numbers on how far these stocks could swin[...]
Read more
Top News

US Stocks Mixed; Enovix Shares Jump

BY Avi Kapoor  • October 12, 2026October 12, 2026
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.4% on Monday. Following the market opening Monday, the Dow traded up 0.36% to 51,842.74 while the NASDAQ fell 0.16% to[...]
Read more
Top News

CVS Health’s Aetna Says Strong Medicare Star Ratings Boost Confidence

BY Vandana Singh  • October 9, 2026October 9, 2026
CVS Health Corp. (NYSE:CVS) said Thursday that more than 69% of its Aetna subsidiary’s Medicare Advantage members are enrolled in 2027 plans rated four stars or higher by the Centers for Medicare[...]
Read more
Top News

Anduril Unveils $3.7 Billion Submarine Plant as U.S. Ramps Up Naval Production

BY Caroline Ryan  • October 6, 2026October 7, 2026
Anduril Industries laid out a $3.7 billion plan to build a Maryland shipyard aimed at turning out key hardware for the U.S. Navy’s Virginia-class submarines. The effort pairs private spending with a p[...]
Read more
Top News

Trump Expects Canada Trade Deal, Diesel’s Problem and More: This Week in Economics

BY Mohd Haider  • October 4, 2026October 5, 2026
It’s been an eventful weekend in the world of politics, markets and the U.S. economy. From President Donald Trump’s latest trade comments to diesel prices, gold, jobs and proposed changes to Head Star[...]
Read more
Top News

Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports

BY Vandana Singh  • October 1, 2026October 2, 2026
Novo Nordisk A/S (NYSE:NVO) on Thursday presented a post hoc analysis from a STEP UP trial sub-population, indicating that Wegovy (pooled semaglutide 7.2 and 2.4 mg) effectively reduced liver fat in o[...]
Read more
Top News
1 2 3 … 305 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551